Your browser doesn't support javascript.
loading
SIK2: A critical glucolipid metabolic reprogramming regulator and potential target in ovarian cancer.
Hu, Dan; Du, JunHong; Xing, YiJuan; Cheng, YueMei; He, RuiFen; Liang, XiaoLei; Li, HongLi; Yang, YongXiu.
Affiliation
  • Hu D; The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
  • Du J; Key Laboratory for Gynecologic Oncology Gansu Province, Lanzhou, Gansu, China.
  • Xing Y; The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
  • Cheng Y; Key Laboratory for Gynecologic Oncology Gansu Province, Lanzhou, Gansu, China.
  • He R; The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
  • Liang X; Key Laboratory for Gynecologic Oncology Gansu Province, Lanzhou, Gansu, China.
  • Li H; The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, China.
  • Yang Y; Key Laboratory for Gynecologic Oncology Gansu Province, Lanzhou, Gansu, China.
J Obstet Gynaecol Res ; 49(8): 2000-2009, 2023 Aug.
Article in En | MEDLINE | ID: mdl-37317594
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Protein Serine-Threonine Kinases Limits: Female / Humans Language: En Journal: J Obstet Gynaecol Res Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2023 Document type: Article Affiliation country: China Country of publication: Australia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Protein Serine-Threonine Kinases Limits: Female / Humans Language: En Journal: J Obstet Gynaecol Res Journal subject: GINECOLOGIA / OBSTETRICIA Year: 2023 Document type: Article Affiliation country: China Country of publication: Australia